AMI Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

AMI Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Sell	2,613 -139	-5%	-$66.4K	0.09%	39
2025 Q4	$1.6M	Sell	2,752 -674	-20%	-$344K	0.09%	43
2025 Q3	$1.57M	Sell	3,426 -14	-0.4%	-$5.22K	0.09%	44
2025 Q2	$1.04M	Sell	3,440 -2,060	-37%	-$614K	0.06%	49
2025 Q1	$1.82M	Buy	5,500 +522	+10%	+$172K	0.11%	48
2024 Q4	$1.54M	Sell	4,978 -35	-0.7%	-$9.84K	0.08%	51
2024 Q3	$1.06M	Sell	5,013 -472	-9%	-$121K	0.06%	66
2024 Q2	$1.54M	Sell	5,485 -4,133	-43%	-$984K	0.08%	51
2024 Q1	$2.57M	Buy	9,618 +4,845	+102%	+$1.14M	0.13%	62
2023 Q4	$1.1M	Buy	+4,773	New	+$835K	0.06%	69

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AMI Asset Management's MDGL Position: Q1 2026 in Review

AMI Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 5.1% in Q1 2026, selling an estimated $66.4K and leaving 2,613 shares worth $1.37M. The position accounts for 0.09% of the portfolio, ranked #39.

AMI Asset Management first reported a position in MDGL in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.57M in Q1 2024. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

AMI Asset Management held 2,613 shares of Madrigal Pharmaceuticals worth $1.37M as of Q1 2026.
AMI Asset Management sold 139 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $66.4K.
Madrigal Pharmaceuticals made up 0.09% of AMI Asset Management's portfolio in Q1 2026, its #39 holding.
AMI Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
AMI Asset Management's Madrigal Pharmaceuticals position peaked at $2.57M in Q1 2024.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on AMI Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.